The ectopic expression of several members of the Bcl-2 family of anti-apoptotic proteins is a promising strategy to improve the viability of hybridoma cells in culture. However, the impact of post-translational modifications on the function of these proteins in murine hybridomas is unknown. To address this issue, the anti-apoptotic properties of a mutant of Bcl-xL devoid of the so-called ''loop domain'' (Bcl-xLD46-83) were investigated using the Sp2 / O-Ag14 hybridoma model. Clones of Sp2 / O-Ag14 cells expressing Bcl-xLD46-83 exhibited resistance against L-glutamine deprivation to similar levels than cells expressing the wild type protein. In contrast, protection against the cytotoxic effects of cycloheximide (CHX) was highly dependent on the level of expression of the Bcl-xLD46-83 mutant. Analysis of the growth behaviour of the transfected cells showed that Bcl-xLD46-83 was superior to the wild type protein in prolonging Sp2 / O-Agl4 cell viability in stationary batch culture. Furthermore, the prolongation of cell viability in batch culture was directly proportional to the level of expression of the mutated protein. Our results indicate that removal of the loop domain improves the anti-apoptotic activity of Bcl-xL in hybridoma cells grown in stationary batch culture.
Introduction
cell lines, with the expectation that this will result in increased monoclonal antibody productivity. Cell death by apoptosis is a major factor limiting the One strategy that may prove effective in improving viability, and by consequence the productivity, of hybridoma cell viability is the ectopic expression of murine hybridomas and other mammalian cell lines of anti-apoptotic genes of the Bcl-2 family. Several biotechnological interest (Al-Rubeai and Singh 1998;  groups have reported increases in hybridoma viability Cotter and Al-Rubeai 1995) . Stresses such as nutrient in stationary batch culture following the overexpreslimitation, anoxia and hydrodynamic stress have been sion of Bcl-2 (Fassnacht et al. 1998; Itoh et al. 1995 ; shown to be the principal triggers of cell death in Simpson et al. 1997; Terada et al. 1997) , Bcl-xL batch or perfusion hybridoma cell cultures (Franek (Charbonneau and Gauthier 2000) and the adenovirus 1995; Massie 1994a, 1994b; Singh et al. Bcl-2 homologue E1B-19K (Mercille et al. 1999 ). 1994). Intense efforts have been made in order to find However, the extent of the increase in viability reways to delay the induction of apoptosis in hybridoma sulting from the overexpression of Bcl-2 proteins is variable and clearly dependent on the cellular context. Cell line and cell maintenance For example, while the expression of Bcl-2 in the NS / O myeloma failed to prolong cell survival (Fujita The murine hybridoma Sp2 / O-Agl4 (ATCC CRL et al. 1997; Murray et al. 1996) , EIB-19K markedly 1581) was obtained from the American Type Tissue increased the viability of this cell line (Mercille et al. Collection (Rockville, MD) and maintained in Is-1999 sub-cellular localisation (Fadeel et al. 1999) . The determination of the tertiary structure of BclPlasmid contructs and cell transfection xL revealed the presence of a long, unstructured region located between the al and a2 helices (Much-A mutant of Bcl-xL (Bcl-xL D46-83) devoid of the more et al. 1996) . This ''loop domain'', spanning loop domain was obtained following a two-step PCR amino acids 26 to 83 in Bcl-xL, has been shown to be procedure (Pont-Kingdon 1994 (Ito et al. 1997) . Similarly, de-83 of Bcl-xL, which correspond to part of the loop phosphorylation of residues Thr 56, Thr 74, and Ser domain, by four alanine residues (indicated in bold in 87 has been linked to the rapid ubiquitination and the sequence). This mutant has been shown by others proteosome-mediated degradation of Bcl-2 (Dimto possess increased anti-apoptotic activity (Chang et meler et al. 1999 1.7 mM NaH P0 , 150 mM NaCl, pH 7.4) as de- 2 4 Reagents scribed previously (Charbonneau and Gauthier 2000) . Unless otherwise stated, all reagents were obtained The extracts were stored at 280 8C until needed. form Canadian Life Technologies (Burlington, ON).
Proteins were fractionated on a 12% PAGE-SDS gel, transferred onto a Hybond-P membrane (Amershamresuspended in fresh culture media at a density of 5 3
Pharmacia Biotech, Baie-d'Urfe, QC), and processed 10 cells ml in 25 cm flasks and cultured as for Western analysis using rabbit polyclonal anti-HA described above. Cell viability was determined daily (Y-11) or anti-Bcl-xL (S-18) primary antibodies and a using the trypan blue exclusion assay: an aliquot of goat anti-rabbit IgG secondary antibody coupled to cells was diluted in 0.04% trypan blue dye (Sigma) horseradish peroxidase (all from Santa Cruz Biotechdissolved in PBS. The viable (membrane-intact) and nology Inc, Santa Cruz, CA). Detection was perdead cells were then counted using a Neubauer formed using the ECL-Plus Chemiluminescence kit hemacytometer. Each result is the average 6 standard and Hyperfilm-ECL autoradiography film (Amersham deviation of at least 4 determinations. Pharmacia), as instructed by the manufacturer. Quantification of the relative abundance of the BclxL-HA and Bcl-xL D46-83-HA proteins was carried Results out using the AlphaEase software (Alpha-Innotech, San Leandro, CA).
Expression of a loop domain-deficient mutant of Bcl-xL in Sp2 /O-Ag14 cells MTT assay
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Three Sp2 / O-Ag14 clones stably expressing the loop Cells (1 3 10 ) were incubated in a total volume of domain-deficient Bcl-xL (Sp2D46-83) and two clones 100 ml in 96-well plates in the presence or absence of 21 expressing wild-type Bcl-xL (Sp2-Bcl-xL) were ob-25 mg ml CHX (Sigma). Alternatively, cells were tained and analysed by Western analysis (Figure 1 ). incubated in Iscove's media lacking L-Gln (Sigma).
Using an anti-HA antibody, we found that the three Cells were incubated at 37 8C tor 3 h (CHX) or 4 h Sp2D46-83 clones expressed increasingly higher (L-Gln deprived) before the addition of 25 ml of MTT 21 amounts of the mutant protein, in ratios of approxidye (Sigma; 5 mg ml dissolved in PBS). Two h mately 1:2:4 ( Figure 1A ). We therefore labelled these later, 100 ml of lysis buffer (20% SDS in 50% N-N9-low med clones Sp2D46-83 , Sp2D46-83 , and dimethylformamide, pH 4.7) was added to each well high Sp2A4D83 , to reflect the relative levels of expresand the plates were incubated at 37 8C overnight.
sion of the mutated Bcl-xL protein in these cells. The Optical density readings were performed at 570 nm expression level of each of the loop domain-deficient using a PowerWaveX microplate reader (Bio-Tek Bcl-xL was considerably higher than the wild type Instruments, Inc., Winooski, VT). Results are exlow protein, with the Sp2D46-83 clone expressing appressed as the average 6 standard deviation of three proximately 4 fold more Bcl-xL than the Sp2-Bcl-xL independent experiments.
clones. The wild-type Bcl-xL protein appeared as a doublet DNA fragmentation of closely migrating bands, which was most evident when an anti-Bcl-xL antibody was used ( Figure 1B ). Five hundred thousand cells were collected and This doublet has been ascribed as post-translational washed once with PBS. The cell pellet was lysed with modifications, most likely phosphorylation, affecting 50 ml of lysis buffer (10 mM Tris-HCI pH 8, 1 mM 21 the Bcl-xL protein (Chang et al. 1997; Haldar et al. EDTA pH 8, 0 .5% N-lauroyl sarcosine, 0.25 mg ml 21 1996). Interestingly, the loop domain-deleted mutants proteinase K and 0.02 mg ml RNAse A) and migrated as a sharp, single band, suggesting that the incubated for 5 min at 50 8C. To further test the potential of the loop domaindeleted Bcl-xL protein to protect against apoptosis, we exposed our transfected cells to CHX, a protein synthesis inhibitor previously shown to rapidly induce apoptosis in the Sp2 / O-Ag14 cell line and related hybridomas (Gauthier et al. 1996; Perreault and Lemieux 1993) . As shown in Figure 3A , the control cells rapidly died in the presence of CHX, while expression of the wild-type Bcl-xL significantly protected against cell death. DNA fragmentation analysis confirmed that the cells died by apoptosis ( Figure  3B) . Expression of the mutated Bcl-xL protected Sp2 / O-Ag14 cells against CHX-induced apoptosis. However, in contrast to the L-Gln depletion data ( Figure  2 ), the extent of the inhibition was clearly a function of the expression levels of the Bcl-xLD46-83 protein ( Figure 3A and B). Effectively, even though it expressed higher levels of Bcl-xL protein, the Sp2D46-low 83 clone showed a greater sensitivity to the cytotoxic effect of CHX that the Sp2-Bcl-xL cells (Figure   med   3A ). On the other hand, both Sp2D46-83 and high Sp2D46-83 clones were at least as resistant as the SP2-Bcl-xL clone towards CHX-induced cell death ( Figure 3A) . These results indicate that, while the Bcl-xLD46-83 protein is effective in inhibiting CHXinduced apoptosis in Sp2 / OAg14 cells, the removal Massie 1994a; Simpson et al. 1998) . We therefore tested the ability of the mutated Bcl-xL protein to protect against the loss of cell viability that accompanies L-Gln deprivation. In agreement with our previous observations (Charbonneau and Gauthier 2000) , the wild type Bcl-xL significantly protected Sp2 / O-Ag14 cells against apoptosis under conditions of the loop domain significantly decreased the specific activity of the Bcl-xL molecule. They also suggest that the level of protection afforded by Bcl-xLD46-83 varies depending on the apoptotic stimuli.
Culture behaviour of the Sp2D46-83 clones
We next determined the effect of the mutated Bcl-xL protein on the viability of hybridoma cells under prolonged culture conditions. The pTEJ8-transfected cells behaved as expected in stationary batch culture (Charbonneau and Gauthier viable cell density of 21,3 3 10 cells ml attained on day 6. Each of the Sp2D46-83 clones also showed improved viability under prolonged culture conditions ( Figures 4A and B) . Remarkably, the extent of the increase in Sp2 / O-Ag14 cell survival, as well as the maximal density of viable cells, was directly proportional to the level of expression of Bcl-xLD46-83 ( Figures 4A and B) . Most importantly, the Sp2D46-med 83 clone, which was as resistant as the Sp2-Bcl-xL cells to the cytotoxic action of CHX (Figure 3) , exhibited a significantly greater survival in stationary batch culture than the cells expressing the wild type protein. viability under prolonged culture conditions. Effec-tively, the total culture time for this clone (defined resulted in a decrease in the protection against apophere as the time required to achieve less than 5% tosis induced by Taxol but not ara-C or etoposide viability) was doubled compared to the pTEJ8-trans- (Fang et al. 1998) . This may be caused by the presfected cells. This effect was not related to the greater ence, in the loop domain, of amino acid residues that expression levels of the loop domain-deleted protein, play a positive role in the function of Bcl-xL. For med since the Bcl-xLD46-83 clone was as effective as example, mutating Ser 70 to an alanine residue yields Bcl-xL in protecting Sp2 / O-Ag14 cells against two an unphosphorylated Bcl-2 protein with decreased apoptotic stresses (CHX exposure and L-Gln deprivaanti-apoptotic properties (Yokote et al. 2000) . In tion) (Figure 2,3) . This clearly shows that the mutacontrast, mutation of residues Thr 56, Thr 74, and Ser genesis of Bcl-2 proteins can improve their potency in 87 of Bcl-2 prevented its degradation via the ubiquitin B cell hybridomas, leading to greater cell survival in pathway, leading to an increased cellular resistance to stationary batch culture. Our results therefore confirm apoptosis (Dimmeler et al. 1999 ). It will be interestand extend those of Figueroa et al. (2001) , who have ing to determine whether Bcl-xL proteins that have recently showed that a loop domain-deficient Bcl-2 been mutated at selected amino acid residues to molecule lead to a greater protection of CHO and prevent specific post-translational modifications with-BHK cells against growth factor withdrawal.
out affecting others could be even more useful in Interestingly, while our Bcl-xLD46-83 clones increasing the resistance of hybridoma cells to culture showed enhanced viability in batch culture, they stresses. behaved similarly to the Bcl-xL expressing cells when
In conclusion, the data presented in this report cultured in the absence of L-Gln. This suggests that, demonstrate that the mutagenesis of Bcl-xL can lead while L-Gln exhaustion constitutes an important trigto greater improvements in the viability of biotechger of apoptosis in murine hybridoma cultures (Mernologically relevant cell lines in batch culture. Further cille and Massie 1994a; Simpson et al. 1998) , other studies are required in order to determine whether stresses participate to limit cell viability. According to specific point mutations of Bcl-2 proteins could be our data, such stresses could be distinguished from more advantageous, as well as to examine the effect L-Gln starvation by their greater response to the of the mutagenized proteins on antibody productivity. inhibitory effects ot Bcl-xL. Interestingly, the extent Finally, our results stress the importance of using of the increase in cell viability in batch culture closely appropriate apoptotic stimuli when investigating the mimicked the relative resistance of each clone to relative effectiveness of anti-apoptotic Bcl-2 proteins CHX induced apoptosis, indicating that the molecular in murine hybridomas. events triggered by the culture stresses may share some of the signalling mechanisms responsible for the cytotoxic effect of CHX. Acknowledgements The ability of the Bcl-xLD46-83 mutant to protect against apoptosis in the murine hybridoma Sp2 / O-´Ẃ e would like to thank Dr. Real Lemieux, HemaAg14 cell line was dependent on the type of deathQ uebec, for the gift of the pTEJ8 vector. This work stimuli. Effectively, both the mutated Bcl-xL and the was supported by a grant form the Laurentian Uniwild type protein were equally efficient in improving versity Research Fund and the Natural Sciences and the survival of Sp2 / O-Ag14 cells following L-Gln Engineering Research Council of Canada (to ERG). deprivation, and this effect did not depend on the expression levels of the loop domain-deleted mutant (Figure 2) . In marked contrast, protection against the References cytotoxic effect of CHX was directly proportional to the expression levels of Bcl-xLD46-83 (Figure 3) . In 
